Cellectar Biosciences, Inc. (CLRB) stock
CLRBNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.92−0.09 (-8.88%)
Close on Nov 17, 2026Market cap $8.70MP/E –Yield –
Cellectar Biosciences cash
Cash and short-term investments held at the end of each period.
Cellectar Biosciences's cash was $33.99M at Jun 30, 2026. For fiscal 2025 it was $13.20M, down 43.3% from the year before. Over ten years it grew 12.9% a year on average. The highest annual figure on record is $57.17M in fiscal 2020.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.20M | -43.3% |
| FY2024 | Dec 31, 2024 | $23.29M | +143.5% |
| FY2023 | Dec 31, 2023 | $9.56M | -51.9% |
| FY2022 | Dec 31, 2022 | $19.87M | -44.4% |
| FY2021 | Dec 31, 2021 | $35.70M | -37.5% |
| FY2020 | Dec 31, 2020 | $57.17M | +438.5% |
| FY2019 | Dec 31, 2019 | $10.61M | -20.3% |
| FY2018 | Dec 31, 2018 | $13.31M | +32.3% |
| FY2017 | Dec 31, 2017 | $10.06M | -12.5% |
| FY2016 | Dec 31, 2016 | $11.50M | +193.9% |
| FY2015 | Dec 31, 2015 | $3.91M | -58.5% |
| FY2014 | Dec 31, 2014 | $9.42M | +289.6% |
| FY2013 | Dec 31, 2013 | $2.42M | -48.3% |
| FY2012 | Dec 31, 2012 | $4.68M | -15.0% |
| FY2011 | Dec 31, 2011 | $5.51M | +717.2% |
| FY2010 | Dec 31, 2010 | $673.74K | -31.3% |
| FY2009 | Dec 31, 2009 | $980.13K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $33.99M | +207.9% |
| Q1 FY2026 | Mar 31, 2026 | $8.35M | -40.0% |
| Q4 FY2025 | Dec 31, 2025 | $13.20M | -43.3% |
| Q3 FY2025 | Sep 30, 2025 | $12.55M | -63.4% |
| Q2 FY2025 | Jun 30, 2025 | $11.04M | -57.3% |
| Q1 FY2025 | Mar 31, 2025 | $13.91M | -65.3% |
| Q4 FY2024 | Dec 31, 2024 | $23.29M | +143.5% |
| Q3 FY2024 | Sep 30, 2024 | $34.26M | +80.5% |
| Q2 FY2024 | Jun 30, 2024 | $25.87M | +402.0% |
| Q1 FY2024 | Mar 31, 2024 | $40.03M | +215.6% |
| Q4 FY2023 | Dec 31, 2023 | $9.56M | -51.9% |
| Q3 FY2023 | Sep 30, 2023 | $18.99M | +6.8% |
| Q2 FY2023 | Jun 30, 2023 | $5.15M | -79.2% |
| Q1 FY2023 | Mar 31, 2023 | $12.68M | -58.6% |
| Q4 FY2022 | Dec 31, 2022 | $19.87M | -44.4% |
| Q3 FY2022 | Sep 30, 2022 | $17.79M | -55.9% |
| Q2 FY2022 | Jun 30, 2022 | $24.81M | -47.0% |
| Q1 FY2022 | Mar 31, 2022 | $30.63M | -42.9% |
| Q4 FY2021 | Dec 31, 2021 | $35.70M | -37.5% |
| Q3 FY2021 | Sep 30, 2021 | $40.34M | +114.1% |
| Q2 FY2021 | Jun 30, 2021 | $46.78M | +108.4% |
| Q1 FY2021 | Mar 31, 2021 | $53.63M | +656.1% |
| Q4 FY2020 | Dec 31, 2020 | $57.17M | +438.5% |
| Q3 FY2020 | Sep 30, 2020 | $18.84M | +41.7% |
| Q2 FY2020 | Jun 30, 2020 | $22.45M | +33.2% |
| Q1 FY2020 | Mar 31, 2020 | $7.09M | -32.4% |
| Q4 FY2019 | Dec 31, 2019 | $10.61M | -20.3% |
| Q3 FY2019 | Sep 30, 2019 | $13.30M | -19.0% |
| Q2 FY2019 | Jun 30, 2019 | $16.85M | +297.8% |
| Q1 FY2019 | Mar 31, 2019 | $10.49M | +52.6% |
| Q4 FY2018 | Dec 31, 2018 | $13.31M | +32.3% |
| Q3 FY2018 | Sep 30, 2018 | $16.43M | +187.4% |
| Q2 FY2018 | Jun 30, 2018 | $4.24M | -49.4% |
| Q1 FY2018 | Mar 31, 2018 | $6.88M | -38.8% |
| Q4 FY2017 | Dec 31, 2017 | $10.06M | -12.5% |
| Q3 FY2017 | Sep 30, 2017 | $5.72M | +1.3% |
| Q2 FY2017 | Jun 30, 2017 | $8.37M | – |
| Q1 FY2017 | Mar 31, 2017 | $11.24M | – |
| Q4 FY2016 | Dec 31, 2016 | $11.50M | – |
| Q3 FY2016 | Sep 30, 2016 | $5.65M | – |
See a number that looks wrong?